M&A Deal Summary

Patheon BV Acquires Agere Pharmaceuticals

On March 20, 2015, Patheon BV acquired life science company Agere Pharmaceuticals

Acquisition Highlights
  • This is Patheon BV’s 3rd transaction in the Life Science sector.
  • This is Patheon BV’s 1st transaction in the United States.
  • This is Patheon BV’s 1st transaction in Oregon.

M&A Deal Summary
Date 2015-03-20
Target Agere Pharmaceuticals
Sector Life Science
Buyer(s) Patheon BV
Deal Type Add-on Acquisition

Target

Agere Pharmaceuticals

Bend,, Oregon, United States
Agere Pharmaceuticals, Inc., a privately-held CDMO, that specializes in improving the absorption rate of medications (bioavailability).

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Patheon BV

Durham, North Carolina, United States
Category Company
Founded 1974
Sector Life Science
Employees5,900
Revenue 1.9B USD (2016)
DESCRIPTION

Patheon BV is a global provider of pharmaceutical development and manufacturing services. With approximately 9,000 professionals worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help clients of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. A Healthier World. Delivered.

DEAL STATS #
Overall 3 of 4
Sector (Life Science) 3 of 4
Type (Add-on Acquisition) 3 of 4
State (Oregon) 1 of 1
Country (United States) 1 of 2
Year (2015) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-14 Banner Pharmacaps Europe B.V.

Tilburg, Netherlands

Banner Pharmacaps, engages in the research, development, and manufacture of soft gelatin capsule technology, adding a new proprietary products and technology business.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-01 IRIX Pharmaceuticals

Florence,, South Carolina, United States

IRIX Pharmaceuticals company that specializes in making difficult to manufacture Active Pharmaceutical Ingredients (API) for drugs from early and late development, through commercial launch.

Buy -
Mergr

Product

Company

Legal